Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.29M Buy
115,000
+77,000
+203% +$3.23M 1.51% 11
2026
Q1
$1.86M Buy
38,000
+28,000
+280% +$1.47M 0.84% 41
2025
Q4
$529K Hold
10,000
0.2% 117
2025
Q3
$614K Hold
10,000
0.22% 109
2025
Q2
$532K Sell
10,000
-60,000
-86% -$2.57M 0.2% 111
2025
Q1
$2.48M Sell
70,000
-85,000
-55% -$3.15M 1.01% 41
2024
Q4
$5.4M Buy
155,000
+55,000
+55% +$1.94M 1.83% 9
2024
Q3
$3.88M Sell
100,000
-10,000
-9% -$367K 1.33% 25
2024
Q2
$3.9M Sell
110,000
-10,000
-8% -$322K 1.42% 21
2024
Q1
$3.98M Buy
+120,000
New +$4.47M 1.27% 26
2023
Q4
Sell
-20,000
Closed -$917K 131
2023
Q3
$917K Buy
+20,000
New +$905K 0.31% 103

Other funds holding CALX

Formula Growth's CALX Position: Q2 2026 in Review

Formula Growth increased its Calix (CALX) stake by 203% in Q2 2026, buying an estimated $3.23M and bringing the position to 115,000 shares worth $4.29M. The position accounts for 1.51% of the portfolio, ranked #11.

Formula Growth first reported a position in CALX in Q3 2023 and has held it in 11 quarters since. The position peaked at $5.4M in Q4 2024. 287 funds tracked by Wall St. Rank hold CALX as of Q2 2026.

  • Formula Growth held 115,000 shares of Calix worth $4.29M as of Q2 2026.
  • Formula Growth bought 77,000 Calix shares in Q2 2026, an estimated $3.23M.
  • Calix made up 1.51% of Formula Growth's portfolio in Q2 2026, its #11 holding.
  • Formula Growth first reported a position in Calix in Q3 2023 and has held it in 11 quarters since.
  • Formula Growth's Calix position peaked at $5.4M in Q4 2024.
  • 287 funds tracked by Wall St. Rank held Calix as of Q2 2026.

Based on Formula Growth's 13F filing for Q2 2026, filed 17 Aug 2026.